Trial intelligence / Profile preview

Enhanced recovery after laparotomy with different doses of dexmedetomidine PCIA

ChiCTR-IPR-17010657Phase 4Not yet recruiting

Sponsor
Cancer Hospital of Guangxi Medical University
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in postoperative pain, sponsored by Cancer Hospital of Guangxi Medical University. Primary endpoints: Ramsay Sedation Score, Visual Analogue Scale Score and 9 more. Planned start Mar 2017; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR-IPR-17010657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17010657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call